Literature DB >> 10981532

Elevation of plasma homocysteine levels associated with acute myocardial infarction.

M P Senaratne1, J Griffiths, J Nagendran.   

Abstract

OBJECTIVE: To study the effect of acute myocardial infarction (AMI) on plasma homocystein (Hcy) levels, to determine the optimal time to measure this risk factor for coronary artery disease.
DESIGN: A prospective case study.
SETTING: The Division of Cardiac Sciences, Grey Nuns Hospital in Edmonton. PATIENTS: Sixty-two patients (40 men, 22 women) admitted to hospital with AMI. INTERVENTION: Measurement of Hcy levels within 48 to 72 hours of admission and at 6 weeks after discharge from the Coronary Care Unit. In a second group of 15 patients, the Hcy levels were measured on hospital days 1 and 3. MAIN OUTCOME MEASURE: Comparison of the Hcy levels measured at the time of AMI and after discharge.
RESULTS: Mean (and standard error of the mean) Hcy level measured during the AMI (13.6 [0.98] micromol/L) was significantly higher (p < 0.05) than at 6 weeks (12.1 [1.01] micromol/L). Based on the 48- to 72-hour and 6-week determinations, 31 and 21 patients, respectively, had abnormal Hcy levels (greater than 12 micromol/L) (p < 0.001). In the separate group of 15 patients, the Hcy level measured on day 3 (9.7 [0.6] micromol/L) was noted to be significantly higher (p < 0.01) than on day 1 (7.7 [0.8] micromol/L).
CONCLUSIONS: There is an elevation of Hcy during AMI that may be related to an increase in the acute-phase reactant proteins. Thus, Hcy measurement should be deferred for 6 weeks in order to determine the true baseline level.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981532

Source DB:  PubMed          Journal:  Clin Invest Med        ISSN: 0147-958X            Impact factor:   0.825


  7 in total

1.  Total homocysteine, diet, and lipid profiles in type 1 and type 2 diabetic and nondiabetic adolescents.

Authors:  Melissa Spezia Faulkner; Wei-Hsun Chao; Savitri K Kamath; Laurie Quinn; Cynthia Fritschi; Jack A Maggiore; Robert H Williams; Robert D Reynolds
Journal:  J Cardiovasc Nurs       Date:  2006 Jan-Feb       Impact factor: 2.083

2.  Homocysteine status and acute myocardial infarction among Tamilians.

Authors:  T Angeline; Rita Mary Aruna; K Ramadevi; G Mohan; Nirmala Jeyaraj
Journal:  Indian J Clin Biochem       Date:  2005-01

3.  Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches.

Authors:  Christos Kalofoutis; Christina Piperi; Anastasios Kalofoutis; Fred Harris; David Phoenix; Jaipaul Singh
Journal:  Exp Clin Cardiol       Date:  2007

4.  Hyperhomocysteinemia, a biochemical tool for differentiating ischemic and nonischemic central retinal vein occlusion during the early acute phase.

Authors:  Kapil Deb Lahiri; Somnath Mukherjee; Sambuddha Ghosh; Suman Mukherjee; Jayanta Dutta; Himadri Datta; Harendra Nath Das
Journal:  Korean J Ophthalmol       Date:  2015-03-17

5.  Translocator Protein Modulation by 4'-Chlorodiazepam and NO Synthase Inhibition Affect Cardiac Oxidative Stress, Cardiometabolic and Inflammatory Markers in Isoprenaline-Induced Rat Myocardial Infarction.

Authors:  Ana Ilic; Dusan Todorovic; Slavica Mutavdzin; Novica Boricic; Biljana Bozic Nedeljkovic; Sanja Stankovic; Tatjana Simic; Predrag Stevanovic; Vera Celic; Dragan Djuric
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

6.  Late thrombosis of sirolimus-eluting stent: a multifactorial problem.

Authors:  Igor Kranjec; Andreja Cerne
Journal:  Case Rep Med       Date:  2009-11-04

7.  Changes in total homocysteine levels after acute stroke and recurrence of stroke.

Authors:  Zhihong Shi; Shuling Liu; Yalin Guan; Meilin Zhang; Hui Lu; Wei Yue; Biao Zhang; Mingzi Li; Jing Xue; Yong Ji
Journal:  Sci Rep       Date:  2018-05-03       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.